GlaxoSmithKline
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. GlaxoSmithKline's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 14% to $29,324,000,000. Profit margin reached 17%. Total operating expenses were $13,337,000,000.
Profit Margin
| 2013 | 26.50B | 5.62B | 21.23% |
|---|---|---|---|
| 2014 | 23.00B | 2.83B | 12.31% |
| 2015 | 23.92B | 8.37B | 35% |
| 2016 | 27.88B | 1.06B | 3.81% |
| 2017 | 30.18B | 2.16B | 7.19% |
| 2018 | 30.82B | 4.04B | 13.13% |
| 2019 | 33.75B | 5.26B | 15.61% |
| 2020 | 34.09B | 6.38B | 18.73% |
| 2021 | 34.11B | 5.09B | 14.94% |
| 2022 | 29.32B | 4.92B | 16.78% |
GSK.SW Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 29.32B | 34.11B | 34.09B | 33.75B | 30.82B | 30.18B | 27.88B | 23.92B | 23.00B | 26.50B |
Cost of revenue | 9.55B | 11.60B | 11.70B | 11.86B | 10.24B | 10.34B | 9.29B | 8.85B | 7.32B | 8.58B |
Gross profit | 19.77B | 22.51B | 22.39B | 21.89B | 20.58B | 19.84B | 18.59B | 15.07B | 15.68B | 17.92B |
Operating exp. | ||||||||||
Research and development | 5.48B | 5.27B | 5.09B | 4.56B | 3.89B | 4.47B | 3.62B | 3.56B | 3.45B | 3.92B |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 13.33B | 16.31B | 16.17B | 15.59B | 13.51B | 13.78B | 12.57B | 12.44B | 11.37B | 12.01B |
Operating income | 16.54B | 5.51B | 7.18B | 6.48B | 5.14B | 3.62B | 2.50B | 11.31B | 3.59B | 7.19B |
Other income (expenses), net | -10.91B | -73M | -217M | -262M | -348M | -99M | -567M | -785M | -628M | -548M |
Income before tax | 5.62B | 5.44B | 6.96B | 6.22B | 4.8B | 3.52B | 1.93B | 10.52B | 2.96B | 6.64B |
Income tax expense | 707M | 346M | 580M | 953M | 754M | 1.35B | 877M | 2.15B | 137M | 1.01B |
Net income | 4.92B | 5.09B | 6.38B | 5.26B | 4.04B | 2.16B | 1.06B | 8.37B | 2.83B | 5.62B |
Earnings per share | ||||||||||
Basic EPS | 1.24 | 1.28 | 1.58 | 1.31 | 1.02 | 0.55 | 0.27 | 2.17 | 0.74 | 1.46 |
Diluted EPS | 1.24 | 1.28 | 1.58 | 1.31 | 1.02 | 0.55 | 0.27 | 2.14 | 0.73 | 1.43 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |